

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fucose catabolic process (GO:0019317) | 7.01239525 |
| 2 | L-fucose metabolic process (GO:0042354) | 7.01239525 |
| 3 | L-fucose catabolic process (GO:0042355) | 7.01239525 |
| 4 | negative regulation of type 2 immune response (GO:0002829) | 6.98900515 |
| 5 | negative regulation of gluconeogenesis (GO:0045721) | 6.84864025 |
| 6 | relaxation of smooth muscle (GO:0044557) | 6.71016208 |
| 7 | relaxation of cardiac muscle (GO:0055119) | 5.96497435 |
| 8 | auditory receptor cell stereocilium organization (GO:0060088) | 5.85460292 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.79669713 |
| 10 | parturition (GO:0007567) | 5.78044333 |
| 11 | negative regulation of T-helper cell differentiation (GO:0045623) | 5.48667231 |
| 12 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 5.48667231 |
| 13 | post-embryonic morphogenesis (GO:0009886) | 5.37683208 |
| 14 | negative regulation of cAMP-mediated signaling (GO:0043951) | 5.30286226 |
| 15 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.26345332 |
| 16 | T cell migration (GO:0072678) | 5.24651993 |
| 17 | relaxation of muscle (GO:0090075) | 5.08304384 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 4.67560836 |
| 19 | inner ear receptor stereocilium organization (GO:0060122) | 4.64938915 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 4.60740530 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.44196474 |
| 22 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.33827948 |
| 23 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.32256781 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.30199409 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.25747970 |
| 26 | branched-chain amino acid metabolic process (GO:0009081) | 4.23073709 |
| 27 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.20100323 |
| 28 | xenobiotic catabolic process (GO:0042178) | 4.18771090 |
| 29 | ketone body metabolic process (GO:1902224) | 4.10085844 |
| 30 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.08658282 |
| 31 | branched-chain amino acid catabolic process (GO:0009083) | 4.05172546 |
| 32 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.97175673 |
| 33 | regulation of T-helper 1 type immune response (GO:0002825) | 3.97038150 |
| 34 | glycerophospholipid catabolic process (GO:0046475) | 3.96264852 |
| 35 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.94316693 |
| 36 | negative regulation of muscle hypertrophy (GO:0014741) | 3.92223074 |
| 37 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.88254159 |
| 38 | actin-myosin filament sliding (GO:0033275) | 3.87865824 |
| 39 | muscle filament sliding (GO:0030049) | 3.87865824 |
| 40 | potassium ion import (GO:0010107) | 3.82141355 |
| 41 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.79521937 |
| 42 | detection of light stimulus involved in visual perception (GO:0050908) | 3.79521937 |
| 43 | regulation of T cell chemotaxis (GO:0010819) | 3.76804698 |
| 44 | positive regulation of T cell chemotaxis (GO:0010820) | 3.76804698 |
| 45 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.61806157 |
| 46 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.56246482 |
| 47 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.54373656 |
| 48 | negative regulation of muscle contraction (GO:0045932) | 3.53321817 |
| 49 | pigment granule transport (GO:0051904) | 3.47255958 |
| 50 | oxaloacetate metabolic process (GO:0006107) | 3.45304687 |
| 51 | negative regulation of smooth muscle contraction (GO:0045986) | 3.44669170 |
| 52 | fucose metabolic process (GO:0006004) | 3.38341923 |
| 53 | skeletal muscle contraction (GO:0003009) | 3.36537631 |
| 54 | amino-acid betaine transport (GO:0015838) | 3.32417550 |
| 55 | carnitine transport (GO:0015879) | 3.32417550 |
| 56 | positive regulation of protein homodimerization activity (GO:0090073) | 3.28751680 |
| 57 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.28525957 |
| 58 | phenylpropanoid metabolic process (GO:0009698) | 3.25138825 |
| 59 | carnitine shuttle (GO:0006853) | 3.21512331 |
| 60 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.21474588 |
| 61 | actin-mediated cell contraction (GO:0070252) | 3.19677732 |
| 62 | establishment of pigment granule localization (GO:0051905) | 3.19604709 |
| 63 | vasodilation (GO:0042311) | 3.15369977 |
| 64 | negative regulation of receptor activity (GO:2000272) | 3.11640323 |
| 65 | positive regulation of vascular permeability (GO:0043117) | 3.11231685 |
| 66 | creatine metabolic process (GO:0006600) | 3.10779727 |
| 67 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.06077167 |
| 68 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.06077167 |
| 69 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.05598154 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.05150132 |
| 71 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.03004196 |
| 72 | brain morphogenesis (GO:0048854) | 3.02685673 |
| 73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.00260505 |
| 74 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.00016331 |
| 75 | regulation of cAMP-mediated signaling (GO:0043949) | 2.94046433 |
| 76 | cytidine metabolic process (GO:0046087) | 2.92594272 |
| 77 | cytidine catabolic process (GO:0006216) | 2.92594272 |
| 78 | cytidine deamination (GO:0009972) | 2.92594272 |
| 79 | actin filament-based movement (GO:0030048) | 2.89532389 |
| 80 | nitric oxide mediated signal transduction (GO:0007263) | 2.88165366 |
| 81 | fucosylation (GO:0036065) | 2.84861040 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82319444 |
| 83 | succinate metabolic process (GO:0006105) | 2.80322832 |
| 84 | pigment granule localization (GO:0051875) | 2.79244597 |
| 85 | lysine catabolic process (GO:0006554) | 2.77426553 |
| 86 | lysine metabolic process (GO:0006553) | 2.77426553 |
| 87 | regulation of striated muscle contraction (GO:0006942) | 2.77238471 |
| 88 | lymphocyte chemotaxis (GO:0048247) | 2.75389313 |
| 89 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.75243669 |
| 90 | coenzyme catabolic process (GO:0009109) | 2.75142016 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74340350 |
| 92 | regulation of type 2 immune response (GO:0002828) | 2.73602870 |
| 93 | regulation of relaxation of muscle (GO:1901077) | 2.72640637 |
| 94 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.72105297 |
| 95 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.69802887 |
| 96 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.68232756 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67876364 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 2.67447091 |
| 99 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67412427 |
| 100 | adenosine receptor signaling pathway (GO:0001973) | 2.67142044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 6.50508326 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 6.19799959 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.67593779 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.35078734 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.23563598 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.95447345 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71421302 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.68744392 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35636236 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.30393570 |
| 11 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.06414494 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.04822494 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99466327 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92486773 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.76700059 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74091752 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71030918 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68020851 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53809500 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52880923 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50843929 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44974769 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43630264 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41236832 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.39081741 |
| 26 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38897906 |
| 27 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38863159 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37322769 |
| 29 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.36412129 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32547840 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31833579 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31494939 |
| 33 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29975576 |
| 34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28258268 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27034736 |
| 36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23859806 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22951953 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18841289 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18339330 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17565245 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17475189 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16137917 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13535483 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13535483 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12401608 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11222725 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10892501 |
| 48 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10342111 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10255064 |
| 50 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09159173 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07904292 |
| 52 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07082693 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06613321 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05292864 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04779961 |
| 56 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03945191 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02107069 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.00802462 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00067414 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 0.98767589 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98419714 |
| 62 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98215244 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97946080 |
| 64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97946080 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97068650 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96695475 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95973240 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95178137 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93497111 |
| 70 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92539226 |
| 71 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85948549 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85668849 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.84375660 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84033133 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83944158 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83742733 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83045498 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82624102 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.82362095 |
| 80 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82100538 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81023687 |
| 82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80393952 |
| 83 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.80364332 |
| 84 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80359393 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80077973 |
| 86 | NCOR_22424771_ChIP-Seq_293T_Human | 0.80039305 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79949922 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79673793 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79265861 |
| 90 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.79182124 |
| 91 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.79043696 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77173497 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75938248 |
| 94 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75788915 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75281922 |
| 96 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.75166239 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.75137622 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.73330430 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72381403 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.71255022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001661_extended_life_span | 5.71060655 |
| 2 | MP0005377_hearing/vestibular/ear_phenot | 5.14602888 |
| 3 | MP0003878_abnormal_ear_physiology | 5.14602888 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.51434832 |
| 5 | MP0008775_abnormal_heart_ventricle | 3.22557675 |
| 6 | MP0003879_abnormal_hair_cell | 3.16025277 |
| 7 | MP0003646_muscle_fatigue | 3.03172904 |
| 8 | MP0003283_abnormal_digestive_organ | 2.77321894 |
| 9 | MP0000751_myopathy | 2.66417148 |
| 10 | MP0005220_abnormal_exocrine_pancreas | 2.53808569 |
| 11 | MP0005187_abnormal_penis_morphology | 2.40750835 |
| 12 | MP0004272_abnormal_basement_membrane | 2.37454293 |
| 13 | MP0000343_altered_response_to | 2.33143511 |
| 14 | MP0002272_abnormal_nervous_system | 2.32018404 |
| 15 | MP0003045_fibrosis | 2.18566809 |
| 16 | MP0001485_abnormal_pinna_reflex | 2.07523033 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.03668254 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 1.96625628 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.93309136 |
| 20 | MP0004883_abnormal_blood_vessel | 1.85870572 |
| 21 | MP0001502_abnormal_circadian_rhythm | 1.83555922 |
| 22 | MP0000749_muscle_degeneration | 1.81071768 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.77990978 |
| 24 | MP0002971_abnormal_brown_adipose | 1.76045153 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.71533980 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.69220694 |
| 27 | MP0004924_abnormal_behavior | 1.67507938 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.67507938 |
| 29 | MP0005332_abnormal_amino_acid | 1.58807439 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.56451648 |
| 31 | MP0002106_abnormal_muscle_physiology | 1.55934883 |
| 32 | MP0003959_abnormal_lean_body | 1.49696110 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.49487472 |
| 34 | MP0002928_abnormal_bile_duct | 1.38251474 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.31835670 |
| 36 | MP0005595_abnormal_vascular_smooth | 1.30883422 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.28129504 |
| 38 | MP0001984_abnormal_olfaction | 1.27003659 |
| 39 | MP0005671_abnormal_response_to | 1.25726229 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.21800597 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.20985549 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.20946480 |
| 43 | MP0002090_abnormal_vision | 1.19454850 |
| 44 | MP0005369_muscle_phenotype | 1.19129830 |
| 45 | MP0009785_altered_susceptibility_to | 1.19120413 |
| 46 | MP0005266_abnormal_metabolism | 1.18297964 |
| 47 | MP0005164_abnormal_response_to | 1.13254345 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.13062933 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.11870693 |
| 50 | MP0001486_abnormal_startle_reflex | 1.10781656 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.08612090 |
| 52 | MP0005166_decreased_susceptibility_to | 1.08435856 |
| 53 | MP0002972_abnormal_cardiac_muscle | 1.07609194 |
| 54 | MP0005058_abnormal_lysosome_morphology | 0.98369756 |
| 55 | MP0004084_abnormal_cardiac_muscle | 0.98242012 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95737426 |
| 57 | MP0001544_abnormal_cardiovascular_syste | 0.94132314 |
| 58 | MP0005385_cardiovascular_system_phenoty | 0.94132314 |
| 59 | MP0005535_abnormal_body_temperature | 0.94049374 |
| 60 | MP0001324_abnormal_eye_pigmentation | 0.92677347 |
| 61 | MP0003075_altered_response_to | 0.91464373 |
| 62 | MP0002405_respiratory_system_inflammati | 0.88845691 |
| 63 | MP0001756_abnormal_urination | 0.86267374 |
| 64 | MP0004742_abnormal_vestibular_system | 0.85928714 |
| 65 | MP0005330_cardiomyopathy | 0.84787956 |
| 66 | MP0004085_abnormal_heartbeat | 0.84607717 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83743294 |
| 68 | MP0003638_abnormal_response/metabolism_ | 0.83719223 |
| 69 | MP0005448_abnormal_energy_balance | 0.83617523 |
| 70 | MP0003690_abnormal_glial_cell | 0.82674728 |
| 71 | MP0001727_abnormal_embryo_implantation | 0.82640582 |
| 72 | MP0001944_abnormal_pancreas_morphology | 0.81751369 |
| 73 | MP0004147_increased_porphyrin_level | 0.81689500 |
| 74 | MP0003632_abnormal_nervous_system | 0.80679304 |
| 75 | MP0000747_muscle_weakness | 0.79905090 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.77636763 |
| 77 | MP0005670_abnormal_white_adipose | 0.77373148 |
| 78 | MP0002163_abnormal_gland_morphology | 0.77182241 |
| 79 | MP0003866_abnormal_defecation | 0.75102998 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 0.75074846 |
| 81 | MP0002269_muscular_atrophy | 0.74505975 |
| 82 | MP0003329_amyloid_beta_deposits | 0.74205092 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.73941441 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.73835650 |
| 85 | MP0000750_abnormal_muscle_regeneration | 0.73768196 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.73460428 |
| 87 | MP0001664_abnormal_digestion | 0.72934181 |
| 88 | MP0002736_abnormal_nociception_after | 0.72818273 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.72779292 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.72717111 |
| 91 | MP0001881_abnormal_mammary_gland | 0.70201873 |
| 92 | MP0003252_abnormal_bile_duct | 0.69113375 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.67232786 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.65515049 |
| 95 | MP0003787_abnormal_imprinting | 0.63616801 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.62705100 |
| 97 | MP0000604_amyloidosis | 0.60888352 |
| 98 | MP0010630_abnormal_cardiac_muscle | 0.59273077 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.59234267 |
| 100 | MP0005165_increased_susceptibility_to | 0.58944272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral sensorineural hearing impairment (HP:0008619) | 6.12349867 |
| 2 | Polyphagia (HP:0002591) | 5.83406700 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.15876435 |
| 4 | Nemaline bodies (HP:0003798) | 4.07382192 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.97422481 |
| 6 | Hypothermia (HP:0002045) | 3.88722453 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 3.83475082 |
| 8 | Abnormality of the diencephalon (HP:0010662) | 3.82108767 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.71954855 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.50569720 |
| 11 | Abnormal eating behavior (HP:0100738) | 3.48076842 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.44794499 |
| 13 | Long clavicles (HP:0000890) | 3.26575892 |
| 14 | Areflexia of lower limbs (HP:0002522) | 3.19175551 |
| 15 | Hypergonadotropic hypogonadism (HP:0000815) | 3.14430544 |
| 16 | Distal arthrogryposis (HP:0005684) | 3.09612152 |
| 17 | Peritonitis (HP:0002586) | 3.08766932 |
| 18 | Ankyloglossia (HP:0010296) | 3.05965683 |
| 19 | Arthropathy (HP:0003040) | 3.05491770 |
| 20 | Aplastic anemia (HP:0001915) | 3.02468817 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.01459915 |
| 22 | Abnormality of dental color (HP:0011073) | 3.00634404 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.99769059 |
| 24 | Delayed puberty (HP:0000823) | 2.97805288 |
| 25 | Truncus arteriosus (HP:0001660) | 2.97480778 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 2.92280869 |
| 27 | Short 1st metacarpal (HP:0010034) | 2.89819464 |
| 28 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.89819464 |
| 29 | Round ear (HP:0100830) | 2.87584906 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.85419913 |
| 31 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76883856 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 2.75364627 |
| 33 | Bundle branch block (HP:0011710) | 2.73947396 |
| 34 | Toxemia of pregnancy (HP:0100603) | 2.72884517 |
| 35 | Abnormality of oral frenula (HP:0000190) | 2.67061708 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 2.64326603 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.64000601 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.63712312 |
| 39 | Abnormality of the calf musculature (HP:0001430) | 2.63654337 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.62429456 |
| 41 | Abnormality of the 1st metacarpal (HP:0010009) | 2.52171304 |
| 42 | Vertigo (HP:0002321) | 2.50739182 |
| 43 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.49100231 |
| 44 | Retinal atrophy (HP:0001105) | 2.48835985 |
| 45 | Increased muscle lipid content (HP:0009058) | 2.47672778 |
| 46 | Acute hepatic failure (HP:0006554) | 2.47594550 |
| 47 | Short hallux (HP:0010109) | 2.45514018 |
| 48 | Myoglobinuria (HP:0002913) | 2.40753724 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39255338 |
| 50 | Adactyly (HP:0009776) | 2.37796316 |
| 51 | Increased CSF protein (HP:0002922) | 2.35818786 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 2.35710475 |
| 53 | Muscle fiber splitting (HP:0003555) | 2.34235354 |
| 54 | Hyponatremia (HP:0002902) | 2.33679323 |
| 55 | T lymphocytopenia (HP:0005403) | 2.29674755 |
| 56 | Abnormality of lateral ventricle (HP:0030047) | 2.29446820 |
| 57 | Sudden death (HP:0001699) | 2.28201860 |
| 58 | Renal cortical cysts (HP:0000803) | 2.25527313 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.24896500 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23877725 |
| 61 | Ulnar deviation of the wrist (HP:0003049) | 2.23575070 |
| 62 | Cardiomegaly (HP:0001640) | 2.23176845 |
| 63 | Fetal akinesia sequence (HP:0001989) | 2.20115370 |
| 64 | J-shaped sella turcica (HP:0002680) | 2.16320459 |
| 65 | Heart block (HP:0012722) | 2.13807168 |
| 66 | Ulnar deviation of finger (HP:0009465) | 2.12943231 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.12821213 |
| 68 | Palpitations (HP:0001962) | 2.12703565 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.09167648 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.08716702 |
| 71 | Hemiplegia (HP:0002301) | 2.08271351 |
| 72 | Limb hypertonia (HP:0002509) | 2.08079283 |
| 73 | Hypomagnesemia (HP:0002917) | 2.06729891 |
| 74 | Malignant hyperthermia (HP:0002047) | 2.04077536 |
| 75 | Hepatic necrosis (HP:0002605) | 1.99172988 |
| 76 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.98636410 |
| 77 | Increased hepatocellular lipid droplets (HP:0006565) | 1.98367869 |
| 78 | Left ventricular hypertrophy (HP:0001712) | 1.97673845 |
| 79 | Ketosis (HP:0001946) | 1.96194200 |
| 80 | Tetraplegia (HP:0002445) | 1.95812844 |
| 81 | Ventricular tachycardia (HP:0004756) | 1.95756660 |
| 82 | Growth hormone deficiency (HP:0000824) | 1.94809029 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 1.93766458 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93155834 |
| 85 | Polyuria (HP:0000103) | 1.89489147 |
| 86 | Rhabdomyolysis (HP:0003201) | 1.87866853 |
| 87 | Atrioventricular block (HP:0001678) | 1.85991996 |
| 88 | Abnormality of renal resorption (HP:0011038) | 1.84817589 |
| 89 | Abnormality of sodium homeostasis (HP:0010931) | 1.83883177 |
| 90 | Abnormal atrioventricular conduction (HP:0005150) | 1.83236547 |
| 91 | Abnormality of T cell number (HP:0011839) | 1.83224321 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 1.82496696 |
| 93 | Abnormality of magnesium homeostasis (HP:0004921) | 1.80463230 |
| 94 | Protruding tongue (HP:0010808) | 1.79823468 |
| 95 | Hydroureter (HP:0000072) | 1.79718311 |
| 96 | Exertional dyspnea (HP:0002875) | 1.78371504 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 1.78332816 |
| 98 | Short phalanx of the thumb (HP:0009660) | 1.77962346 |
| 99 | Hepatocellular necrosis (HP:0001404) | 1.76025368 |
| 100 | Abnormality of macrophages (HP:0004311) | 1.74133541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.77754975 |
| 2 | OBSCN | 3.72065458 |
| 3 | BLK | 3.63317507 |
| 4 | MAP2K6 | 2.93130353 |
| 5 | TTN | 2.72509923 |
| 6 | FRK | 2.60751954 |
| 7 | PHKG2 | 2.49469187 |
| 8 | PHKG1 | 2.49469187 |
| 9 | LMTK2 | 2.45780597 |
| 10 | MAP3K4 | 2.33252024 |
| 11 | TAF1 | 2.27189670 |
| 12 | PASK | 2.15514815 |
| 13 | FLT3 | 1.87344056 |
| 14 | SYK | 1.78501941 |
| 15 | ABL2 | 1.75639200 |
| 16 | ITK | 1.71758753 |
| 17 | PINK1 | 1.71294670 |
| 18 | MAP4K2 | 1.60329650 |
| 19 | JAK2 | 1.58313304 |
| 20 | TEC | 1.49548635 |
| 21 | MAPKAPK3 | 1.48229464 |
| 22 | TXK | 1.45325179 |
| 23 | NUAK1 | 1.43730779 |
| 24 | PIK3CA | 1.43026049 |
| 25 | VRK2 | 1.34669733 |
| 26 | PRKG1 | 1.21560040 |
| 27 | CSF1R | 1.21010327 |
| 28 | VRK1 | 1.19514083 |
| 29 | NME2 | 1.15775355 |
| 30 | PRKCQ | 1.15757551 |
| 31 | TESK2 | 1.13862249 |
| 32 | BCKDK | 1.13706928 |
| 33 | IKBKB | 1.10147086 |
| 34 | TBK1 | 1.09622278 |
| 35 | KIT | 1.08702542 |
| 36 | MAPK15 | 1.07652525 |
| 37 | PKN2 | 1.04795420 |
| 38 | PRKG2 | 1.04689465 |
| 39 | PRKCE | 1.04565565 |
| 40 | MST4 | 1.03704575 |
| 41 | EIF2AK3 | 1.02314855 |
| 42 | JAK3 | 1.01858356 |
| 43 | MAP4K1 | 1.01580338 |
| 44 | KDR | 0.96381329 |
| 45 | MAP3K7 | 0.94386065 |
| 46 | BTK | 0.93620804 |
| 47 | CAMK2D | 0.92829509 |
| 48 | GRK7 | 0.91852900 |
| 49 | FES | 0.90494580 |
| 50 | LYN | 0.89430820 |
| 51 | TSSK6 | 0.89350432 |
| 52 | MYLK | 0.88956854 |
| 53 | TRPM7 | 0.86286784 |
| 54 | EIF2AK2 | 0.85841128 |
| 55 | ZAP70 | 0.85820812 |
| 56 | ADRBK2 | 0.83903311 |
| 57 | MAPK12 | 0.83546692 |
| 58 | GRK1 | 0.76878442 |
| 59 | HIPK2 | 0.73620840 |
| 60 | DAPK2 | 0.73138959 |
| 61 | MAPK9 | 0.72050741 |
| 62 | MARK1 | 0.71508060 |
| 63 | ERBB3 | 0.68848276 |
| 64 | TIE1 | 0.68125307 |
| 65 | CCNB1 | 0.65548249 |
| 66 | IGF1R | 0.64433412 |
| 67 | ADRBK1 | 0.62859516 |
| 68 | MAPK7 | 0.61432632 |
| 69 | EGFR | 0.59825462 |
| 70 | CSK | 0.59775602 |
| 71 | MUSK | 0.57331015 |
| 72 | TNK2 | 0.56570403 |
| 73 | MARK2 | 0.56230524 |
| 74 | MAP3K2 | 0.56044577 |
| 75 | LCK | 0.55929718 |
| 76 | PIK3CG | 0.54467180 |
| 77 | INSR | 0.53389190 |
| 78 | TAOK1 | 0.52340631 |
| 79 | RPS6KA1 | 0.51445631 |
| 80 | CAMK4 | 0.50610535 |
| 81 | IKBKE | 0.50422431 |
| 82 | MAPK3 | 0.50197474 |
| 83 | AURKA | 0.49890357 |
| 84 | DAPK1 | 0.49017637 |
| 85 | MAPK4 | 0.48020884 |
| 86 | PRKACA | 0.47356998 |
| 87 | ABL1 | 0.47110837 |
| 88 | RPS6KA6 | 0.45715891 |
| 89 | PLK1 | 0.42866295 |
| 90 | FYN | 0.42549863 |
| 91 | PRKCA | 0.41739657 |
| 92 | PRKACB | 0.41726998 |
| 93 | NTRK3 | 0.41474857 |
| 94 | TYK2 | 0.38447990 |
| 95 | PRKCH | 0.38447849 |
| 96 | MAPK13 | 0.37441190 |
| 97 | CAMK2A | 0.36744887 |
| 98 | MAPK1 | 0.35741760 |
| 99 | GSK3A | 0.35668849 |
| 100 | MAP2K3 | 0.35124063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78156306 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.62285384 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.22543091 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.85808024 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35916786 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30406462 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24018274 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.11017679 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.06613355 |
| 10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.03215207 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.86984384 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82440949 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77903089 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71742293 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65933797 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.59484648 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51668699 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49728841 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47490519 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.44797925 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43136256 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37251600 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35907850 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34417202 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.33537623 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30551068 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.27512916 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.24840154 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24233097 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22882735 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20296931 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18651366 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18469907 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.13788835 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11844499 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.09500115 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.07909043 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.06825450 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.02708313 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01319901 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.00193050 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99243331 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96120444 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 0.94740064 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.94397134 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93173209 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.91209168 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86894044 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81782130 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81658393 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80936824 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79763000 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79461164 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76664181 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76270955 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75231036 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71908859 |
| 58 | Proteasome_Homo sapiens_hsa03050 | 0.71694586 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70031061 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69455044 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68625554 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67832242 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67676581 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67269798 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.66841895 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63968250 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63270568 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63180335 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.62789950 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.62418681 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60336181 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58871915 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58003654 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57790777 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56337460 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55800815 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52881021 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52433745 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51511978 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50654699 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50260555 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47640984 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46526068 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46329599 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.44140131 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44036992 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43868978 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43223322 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42088746 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41381470 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41368844 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40696436 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38864668 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38317276 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36821329 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36542190 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35773043 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35645363 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35514287 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34676006 |

